Vident Advisory, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1744347 Alpharetta, GA

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,664,834

+$605,487 QoQ

Shares Held

3,449

+29.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 90.17106407654393.ToString("F0")% Shared 0.ToString("F0")% None 9.828935923456074.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vident Advisory, LLC holds $44,934,093 across 44 Biotechnology names. REGN ranks #4 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	16,063	$7,172,769
2	EXEL	Exelixis, Inc.	148,830	$6,383,317
3	JAZZ	Jazz Pharmaceuticals plc	23,032	$4,354,199
4	REGN	Regeneron Pharmaceuticals, Inc. This page	3,449	$2,664,834
5	ALNY	Alnylam Pharmaceuticals, Inc.	6,457	$2,136,426
6	INSM	INSMED Inc	9,808	$1,603,803
7	GMAB	Genmab A/S	48,379	$1,298,008
8	CYTK	Cytokinetics Inc	17,069	$1,125,017

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,664,834	3,449	+29.3%	Shares	Defined	2026-05-15
2025-12-31	$2,059,347	2,668	-0.6%	Shares	Sole	2026-02-18
2025-09-30	$1,509,693	2,685	+9.6%	Shares	Defined	2025-11-14
2025-06-30	$1,285,725	2,449	-6.6%	Shares	Sole	2025-08-14
2025-03-31	$1,662,951	2,622	-43.9%	Shares	Sole	2025-05-15
2024-12-31	$3,331,565	4,677	+228.7%	Shares	Defined	2025-02-14
2024-09-30	$1,495,914	1,423	-75.8%	Shares	Sole	2024-11-14
2024-06-30	$6,171,647	5,872	-76.3%	Shares	Sole	2024-08-14
2024-03-31	$23,804,300	24,732	+24.5%	Shares	Defined	2024-05-14
2023-12-31	$17,453,376	19,872	-9.1%	Shares	Sole	2024-02-14
2023-09-30	$17,991,549	21,862	—	Shares	Sole	2024-02-21
No filing history on record for this holder in this stock.